Etubics is a biopharmaceutical company that specializes in developing targeted immunotherapies and vaccine products. Etubics was founded in 2003. Etubics' headquarters is located in Seattle, Washington, USA 98119-4007.
Etubics' Chairman & CEO, Frank ... Etubics's Chairman & CEO, Frank R. Jones, currently has an approval
rating of 88%. Etubics's primary competitors are OyaGen, GeoVax & Immunize Rx.
There have been no acquisitions found related to Etubics
Recent investment data cannot be found related to Etubics